ENTA logo

Enanta Pharmaceuticals (ENTA) EBITDA

Annual EBITDA

-$104.51 M
+$18.96 M+15.36%

September 30, 2024

Summary

Performance

1-Year Change

+15.36%

3-Year Change

-0.26%

5-Year Change

-361.31%

15-Year Change

-490.68%

ENTA EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

17.86%
ENTA annual EBITDA is higher than 17.86% of companies in Healthcare sector

High & Low

All-time High

$126.10 M
ENTA annual EBITDA is currently -182.88% below its historical high of $126.10 million

3-Year Low

-$123.48 M

Earnings dates

Last Annual Earnings Report Date

Sep 30, 2024
ENTA previous annual earnings announcement was published on Sep 30, 2024

Next Annual Earnings Report Date

N/A
ENTA next annual earnings announcement has not yet been scheduled

OtherENTAprofitabilitymetrics:

Annual Revenue

$67.64 M
ENTA annual revenue is $67.64 million

Annual Net Income

-$116.05 M
ENTA annual net profit is -$116.05 million

Annual EBIT

-$106.85 M
ENTA annual earnings before interest & taxes is -$106.85 million

Annual EPS

-$5.48
ENTA annual earnings per share is -$5.48

Quarterly EBITDA

-$26.13 M
-$6.02 M-29.95%

September 30, 2024

Summary

Performance

3-Month Change

-29.95%

1-Year Change

-1.67%

3-Year Change

+15.52%

5-Year Change

+15.52%

ENTA Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

17.71%
ENTA quarterly EBITDA is higher than 17.71% of companies in Healthcare sector

High & Low

All-time High

$70.64 M
ENTA quarterly EBITDA is currently -136.98% below its historical high of $70.64 million

3-Year Low

-$37.07 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
ENTA previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 7, 2025
ENTA next earnings announcement is scheduled for Feb 7, 2025

OtherENTAprofitabilitymetrics:

Quarterly Revenue

$14.61 M
ENTA quarterly revenue is $14.61 million

Quarterly Net Income

-$28.82 M
ENTA quarterly net profit is -$28.82 million

Quarterly EBIT

-$26.61 M
ENTA quarterly earnings before interest & taxes is -$26.61 million

Quarterly EPS

-$1.36
ENTA quarterly earnings per share is -$1.36

TTM EBITDA

-$104.51 M
-$429.00 K-0.41%

September 30, 2024

Summary

Performance

3-Month Change

-0.41%

1-Year Change

+15.36%

3-Year Change

-0.26%

5-Year Change

-0.26%

ENTA TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

17.03%
ENTA TTM EBITDA is higher than 17.03% of companies in Healthcare sector

High & Low

All-time High

$149.60 M
ENTA TTM EBITDA is currently -169.86% below its historical high of $149.60 million

3-Year Low

-$126.61 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
ENTA previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 7, 2025
ENTA next earnings announcement is scheduled for Feb 7, 2025

OtherENTAprofitabilitymetrics:

TTM Revenue

$67.64 M
ENTA TTM revenue is $67.64 million

TTM Net Income

-$116.05 M
ENTA TTM net profit is -$116.05 million

TTM EBIT

-$106.85 M
ENTA TTM earnings before interest & taxes is -$106.85 million

TTM EPS

-$5.48
ENTA TTM earnings per share is -$5.48

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$104.51 M
ENTA annual EBITDA is -$104.51 million

Annual Net Income

-$116.05 M
ENTA annual net profit is -$116.05 million

Annual Interest Expense

$10.94 M
ENTA annual interest expense is $10.94 million

Annual Income Tax

-$1.74 M
ENTA annual income tax is -$1.74 million

Annual D&A

$2.34 M
ENTA annual depreciation & amortization is $2.34 million

ENTA EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+15.4%-1.7%+15.4%
3 y3 years-0.3%+15.5%-0.3%
5 y5 years-361.3%+15.5%-0.3%

ENTA EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-0.3%+15.4%-29.9%+29.5%-0.4%+17.4%
5 y5-year-361.3%+15.4%-289.7%+29.5%-514.1%+17.4%
alltimeall time-182.9%+15.4%-137.0%+29.5%-169.9%+17.4%

Enanta Pharmaceuticals EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-$104.51 M(-15.4%)
-$26.13 M(+30.0%)
-$104.51 M(+0.4%)
Jun 2024
-
-$20.10 M(-29.1%)
-$104.08 M(-10.4%)
Mar 2024
-
-$28.34 M(-5.4%)
-$116.17 M(-7.0%)
Dec 2023
-
-$29.95 M(+16.5%)
-$124.91 M(+1.2%)
Sep 2023
-$123.48 M(+3.6%)
-$25.70 M(-20.2%)
-$123.48 M(+0.0%)
Jun 2023
-
-$32.20 M(-13.2%)
-$123.46 M(+0.6%)
Mar 2023
-
-$37.07 M(+30.0%)
-$122.69 M(+3.4%)
Dec 2022
-
-$28.51 M(+11.0%)
-$118.64 M(-0.9%)
Sep 2022
-$119.22 M(+14.4%)
-$25.68 M(-18.3%)
-$119.76 M(-4.2%)
Jun 2022
-
-$31.43 M(-4.8%)
-$125.01 M(-1.3%)
Mar 2022
-
-$33.02 M(+11.5%)
-$126.61 M(+3.4%)
Dec 2021
-
-$29.63 M(-4.2%)
-$122.45 M(+17.5%)
Sep 2021
-$104.25 M(+174.4%)
-$30.93 M(-6.3%)
-$104.25 M(+13.1%)
Jun 2021
-
-$33.02 M(+14.4%)
-$92.19 M(+13.7%)
Mar 2021
-
-$28.87 M(+152.6%)
-$81.10 M(+28.3%)
Dec 2020
-
-$11.43 M(-39.5%)
-$63.20 M(+66.3%)
Sep 2020
-$37.99 M(-195.0%)
-$18.87 M(-14.0%)
-$37.99 M(+222.0%)
Jun 2020
-
-$21.94 M(+100.1%)
-$11.80 M(-179.8%)
Mar 2020
-
-$10.96 M(-179.6%)
$14.78 M(-41.4%)
Dec 2019
-
$13.78 M(+88.1%)
$25.23 M(-36.9%)
Sep 2019
$40.00 M(-56.0%)
$7.32 M(+57.8%)
$40.00 M(-41.0%)
Jun 2019
-
$4.64 M(-1024.3%)
$67.79 M(-21.6%)
Mar 2019
-
-$502.00 K(-101.8%)
$86.44 M(-17.2%)
Dec 2018
-
$28.54 M(-18.7%)
$104.42 M(+14.9%)
Sep 2018
$90.85 M
$35.11 M(+50.7%)
$90.85 M(-17.9%)
Jun 2018
-
$23.30 M(+33.3%)
$110.59 M(+48.0%)
Mar 2018
-
$17.47 M(+16.8%)
$74.72 M(+54.8%)
DateAnnualQuarterlyTTM
Dec 2017
-
$14.96 M(-72.7%)
$48.27 M(+76.9%)
Sep 2017
$26.75 M(-17.7%)
$54.86 M(-536.2%)
$27.29 M(-186.6%)
Jun 2017
-
-$12.58 M(+40.1%)
-$31.50 M(+64.8%)
Mar 2017
-
-$8.98 M(+49.2%)
-$19.12 M(+95.3%)
Dec 2016
-
-$6.02 M(+53.3%)
-$9.79 M(-130.1%)
Sep 2016
$32.50 M(-74.2%)
-$3.93 M(+1892.9%)
$32.50 M(-20.4%)
Jun 2016
-
-$197.00 K(-156.1%)
$40.82 M(-5.5%)
Mar 2016
-
$351.00 K(-99.0%)
$43.17 M(-52.9%)
Dec 2015
-
$36.27 M(+726.5%)
$91.73 M(-27.3%)
Sep 2015
$126.10 M(+542.1%)
$4.39 M(+103.5%)
$126.10 M(+8.0%)
Jun 2015
-
$2.16 M(-95.6%)
$116.74 M(-22.0%)
Mar 2015
-
$48.91 M(-30.8%)
$149.60 M(+56.5%)
Dec 2014
-
$70.64 M(-1519.7%)
$95.57 M(+386.7%)
Sep 2014
$19.64 M(+98.8%)
-$4.98 M(-114.2%)
$19.64 M(-3.0%)
Jun 2014
-
$35.02 M(-784.1%)
$20.25 M(-207.5%)
Mar 2014
-
-$5.12 M(-3.2%)
-$18.84 M(+8.2%)
Dec 2013
-
-$5.29 M(+21.3%)
-$17.41 M(-276.3%)
Sep 2013
$9.88 M(-54.2%)
-$4.36 M(+7.2%)
$9.88 M(-3.4%)
Jun 2013
-
-$4.07 M(+10.2%)
$10.23 M(-5.6%)
Mar 2013
-
-$3.69 M(-116.8%)
$10.83 M(-76.8%)
Dec 2012
-
$22.00 M(-648.3%)
$46.68 M(+116.4%)
Sep 2012
$21.57 M(-20.0%)
-$4.01 M(+15.8%)
$21.57 M(-0.7%)
Jun 2012
-
-$3.47 M(-110.8%)
$21.72 M(-13.8%)
Mar 2012
-
$32.15 M(-1136.2%)
$25.18 M(-461.3%)
Dec 2011
-
-$3.10 M(-19.8%)
-$6.97 M(+80.2%)
Sep 2011
$26.97 M(+224.9%)
-$3.87 M
-$3.87 M
Sep 2010
$8.30 M
-
-

FAQ

  • What is Enanta Pharmaceuticals annual EBITDA?
  • What is the all time high annual EBITDA for Enanta Pharmaceuticals?
  • What is Enanta Pharmaceuticals annual EBITDA year-on-year change?
  • What is Enanta Pharmaceuticals quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Enanta Pharmaceuticals?
  • What is Enanta Pharmaceuticals quarterly EBITDA year-on-year change?
  • What is Enanta Pharmaceuticals TTM EBITDA?
  • What is the all time high TTM EBITDA for Enanta Pharmaceuticals?
  • What is Enanta Pharmaceuticals TTM EBITDA year-on-year change?

What is Enanta Pharmaceuticals annual EBITDA?

The current annual EBITDA of ENTA is -$104.51 M

What is the all time high annual EBITDA for Enanta Pharmaceuticals?

Enanta Pharmaceuticals all-time high annual EBITDA is $126.10 M

What is Enanta Pharmaceuticals annual EBITDA year-on-year change?

Over the past year, ENTA annual EBITDA has changed by +$18.96 M (+15.36%)

What is Enanta Pharmaceuticals quarterly EBITDA?

The current quarterly EBITDA of ENTA is -$26.13 M

What is the all time high quarterly EBITDA for Enanta Pharmaceuticals?

Enanta Pharmaceuticals all-time high quarterly EBITDA is $70.64 M

What is Enanta Pharmaceuticals quarterly EBITDA year-on-year change?

Over the past year, ENTA quarterly EBITDA has changed by -$429.00 K (-1.67%)

What is Enanta Pharmaceuticals TTM EBITDA?

The current TTM EBITDA of ENTA is -$104.51 M

What is the all time high TTM EBITDA for Enanta Pharmaceuticals?

Enanta Pharmaceuticals all-time high TTM EBITDA is $149.60 M

What is Enanta Pharmaceuticals TTM EBITDA year-on-year change?

Over the past year, ENTA TTM EBITDA has changed by +$18.96 M (+15.36%)